Polarean, INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$216Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
54clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Chase Hall | Kansas City, KS | Pulmonary Disease | $166,032.75 |
| Joseph Mammarappallil | Durham, NC | Diagnostic Radiology | $15,737.44 |
| Mario Castro | Kansas City, KS | Pulmonary Disease | $6,006.93 |
| Stella Davies | Cincinnati, OH | Pediatric Hematology-Oncology | $5,116.64 |
| Borna Mehrad | Gainesville, FL | Pulmonary Disease | $4,708.58 |
| Surya Bhatt | Bethlehem, PA | Pulmonary Disease | $3,639.76 |
| Jamie Macleod | Charlottesville, VA | Pulmonary Disease | $3,047.20 |
| George Washko | Boston, MA | Pulmonary Disease | $3,000.00 |
| Gerald Klein | Pittsboro, NC | $2,791.25 | |
| Rajat Walia | Phoenix, AZ | Pulmonary Disease | $367.15 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.